| Date Filed | Type | Description |
| 03/07/2023 |
4
| Patel Chintu (Co-CEO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 733,944 options to buy
@ $0 |
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2020 |
4
| Patel Chintu (Co-CEO and Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/08/2019 |
4
| Patel Chintu (10% Owner) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 28,044 options
@ $14.05, valued at
$394k
Granted 6,459 restricted stock units
@ $0
Exercised 6,107 restricted stock units
@ $0 |
|
| 07/09/2018 |
4
| Patel Chintu (10% Owner) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Acquired 24,753,252 shares
@ $0
Acquired 24,753,252 units
@ $0 |
|
| 07/09/2018 |
SC 13D
| Patel Chintu reports a 17.7% stake in Amneal Pharmaceuticals, Inc. |
| 05/09/2018 |
4
| Patel Chintu (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 24,977 options
@ $15.01, valued at
$374.9k
Granted 6,107 restricted stock units
@ $0 |
|
| 05/09/2018 |
3
| Patel Chintu (Director) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |